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INTRODUCTION 
A. .background 
The biochemical effects of MSH 
Approximately forty years ago, the Cloudman S-91 mel¬ 
anoma was established as a transplantable tumor in DBA/2J 
mice (1). Yasmura et. al. in 1966 were the first to adapt 
the tumor cells to culture (2). The biochemical and morph¬ 
ological response of cultured Cloudman melanoma cells to 
melanotropin (MSH) was described by Wong and Pawelek (3»4). 
They observed dramatic increases in tyrosinase activity and 
melanin content as well as increased generation time when 
cells were exposed to the hormone. Previous studies in vivo 
had produced similar results. Geschwind and Huseby saw 
darkening of coat color and marked increases in tyrosinase 
activity following MSH injections into mice (5)» When mice 
with B-16 melanomas were injected with MSH, Lee et. al. re¬ 
ported an increase in both tyrosinase activity and melano- 
genesis of the tumor (6). 
Bitensky and Demopoulos found that broken-cell prepara¬ 
tions of Cloudman mouse melanoma had adenylyl cyclase activ¬ 
ity which responded to both and p> MSH (7,8), indicating 
that MSH might act through adenosine 3'»5’-monophosphate 
, 
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(cyclic AMP) as a second messenger. Support for this pro¬ 
posed mechanism of action came from further studies in which 
6 2' 
cyclic AIVIP or its analogue, N ,0 -dibutyryl adenosine 3'* 
5'-monophosphate (dibutyryl cyclic AMP), was shown to mimic 
the effects of MSH on S-91 cells in culture (4,9). In addi¬ 
tion, Pawelek et. al. reported a 5 to 50 fold rise in intra¬ 
cellular cyclic AiviP within 10 minutes of addition of MSH 
(10) . 
Later studies have reinforced the role of cyclic AMP in 
cellular regulation of both pigmentation and proliferation. 
Pirstly, a link between cyclic AMP levels and tyrosinase ac¬ 
tivity in Cloudman S-91 melanoma cells has been postulated 
based upon the following observations; (1) In response to 
MSH, maximum levels of both occur during the phase of the 
cell cycle, with the tyrosinase peak following the cyclic AMP 
peak by 8 hr (11); (2) The addition of a partially purified 
cyclic AIVIP-dependent protein kinase to a crude cell extract 
from non-MSH treated cells resulted in a several fold in¬ 
crease in tyrosinase activity (12). Secondly, a link between 
growth characteristics and cyclic AiviP has been made based 
upon studies showing; (1) growth inhibition from high levels 
of dibutyryl cyclic AMP (8 x 10“ M) (13) or cyclic AIVIP (1-10 
-3 
x 10 M) (14); (2) stimulation of proliferation with low 
levels of dibutyryl cyclic AIVIP (10”^lvl) (13); and (3) a major 
cyclic AiviP-dependent protein kinase isolated from cells of a 
' 
, 
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mutant S-91 line (characterized by dependence upon MSH for 
growth) had a somewhat higher activation constant for cyclic 
AMP as compared to the wild type (15)* This could explain 
the mutant cells' requirement of elevated levels of cyclic 
AMP for growth. 
Regulation of melanin synthesis 
While advances have been made in the understanding of 
the regulation of pigmentation, the accepted pathway of mel¬ 
anin synthesis has remained unchallenged for several decades 
(16,17) (Fig. 1). It has been commonly thought that both 
normal and malignant mammalian melanocytes synthesize melanin 
in a pathway controlled exclusively by the enzyme tyrosinase 
(monophenol monoxygenase; monophenol, dihydroxyphenylalanine: 
oxygen oxidoreductase, EC 1.1418.8). There remains some 
controversy as to whether in murine melanoma the two initial 
reactions of (1) the oxidation of tyrosine to L-3t4-dihy- 
droxyphenylalanine (dopa) and (2) the oxidation of dopa to 
dopa quinone are catalyzed by a single enzyme tyrosinase 
(18,19,20,21), or whether there are two separate enzymes, 
i.e. a peroxidase for the first conversion and a dopa oxidase 
for the second conversion (22,23*24). Despite these differ¬ 
ences, it has been generally agreed that once tyrosine was 
converted to dopa quinone, the subsequent oxidation-reduction 
* ': ■ ■ 
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reactions proceeded spontaneously with no further regulatory 
control (25). 
In the past year, however, Logan and Weatherhead have 
observed a post-tyrosinase inhibition of melanin synthesis 
by melatonin in hamster hair follicles (26). Recently, 
Korner and Pawelek reported the isolation of a factor from 
murine melanomas which catalyzes the conversion of dopachrome 
to 5,6-dihydroxyindole-2-carboxylic acid (27) (Fig. 1). In 
addition, another regulatory factor has been isolated that 
inhibits the spontaneous conversion of dopachrome to melanin 
(28). Treatment of cells with MSH results in removal of this 
inhibitory factor. Therefore, recent evidence suggests that, 
contrary to previous thought, there are multiple points of 
regulation in the pathway of melanin biosynthesis. 
Cytotoxicity of melanin precursors 
In 1963* Hochstein and Cohen were the first to comment 
upon the potential cytotoxicity of the intermediates of the 
melanin biosynthetic pathway (29). These precursors are 
polyphenolic and quinone compounds and numerous studies have 
shown that related compounds, such as hydroquinone (30,31.32, 
33) and hydroxyanisole (3^.35). produce selective destruc¬ 
tion of pigmented melanocytes. Two possible mechanisms of 
toxicity were proposed (29): (1) the formation of hydrogen 
. 
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peroxide as a result of the autoxidation of phenolic inter¬ 
mediates, and a subsequent damage to cellular integrity (36) 
or (2) quinone intermediates or products causing oxidative 
inactivation of sulfhydryl-dependent enzymes, essential in 
both energy metabolism (37) and DNA synthesis (38). 
Graham ejt. al. postulated that phenolic compounds whose 
cytotoxicity correlated with their rate of oxidation and 
oxidative potentials formed hydrogen peroxide and free radi¬ 
cals from autoxidation (mechanism one) (39). These investi¬ 
gators also examined the quinone intermediates which result 
from the oxidation of tyrosine for their ability to inhibit 
DNA polymerase <X, a sensitive test for sulfhydryl reagents 
(mechanism two) (40). The greatest affinity for the enzyme 
was shown by a dopa quinone analogue, leading to the conclu¬ 
sion that dopa quinone was the significant toxic metabolite. 
It has been proposed by Lerner that normal and malig¬ 
nant melanocytes possess a mechanism which protects against 
the toxic metabolites being produced continuously as a result 
of melanogenesis (41). However, this protection was viewed 
as somewhat labile. The chance that these melanin precursors 
could cause cellular self-destruction would be increased if 
melanin synthesis were stimulated. This could aid in ex¬ 
plaining the following observations in humans: the appear¬ 
ance of vitiligo in areas of the body which are normally 
hyperpigmented, the occurence of halo nevi and halo metastases 
■ 
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from melanoma, and the association of vitiligo with Addison's 
disease and melanoma (4l). 
Pawelek et. al. were interested in testing the hypoth¬ 
esis that the cytotoxicity of melanin precursors would be 
increased if melanin synthesis were increased. Tyrosine 
(5 mM), the initial precursor in the melanin pathway, and 
its analogue N-acetyl tyrosine (50 mM) were found to be se¬ 
lectively toxic toward melanotic melanoma cells (10). While 
the melanotic cells died after four days of exposure, amel¬ 
anotic variants, characterized by low basal tyrosinase ac¬ 
tivity (42), displayed a decline in growth rate, but no 
mortality (10). If DBA/2J mice with Cloudman melanoma tumors 
were fed a diet high in tyrosine (33°/° wt/wt) for four weeks, 
a 2-5 fold reduction in tumor size was recorded in comparison 
to the control. When these animals were given daily injec¬ 
tions of MSH, the animals on the control diet had increased 
tumor size, while the animals on the tyrosine diet had even 
smaller tumors than those not injected with the hormone (10). 
These results could be explained by the stimulation of mela¬ 
nin synthesis by MSH, thereby increasing the sensitivity of 
the tumor cells to the cytotoxic effects of tyrosine. 
Subsequently, both melanotic Cloudman melanoma cells 
and amelanotic mouse L-cell fibroblasts were exposed to 21 
of the naturally occurring amino acids for a period of six 
days. Only tyrosine (5 mM), dopa (0.1 mM), and tryptophan 
. 
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(5 mM) resulted in selective cytotoxicity in the pigmented 
cell line (25). Since tyrosine and dopa are the principal 
amino acids that serve as precursors in the melanin biosyn¬ 
thetic pathway, their selective toxicity was expected. 
However, Costa et. al. have observed the incorporation of 
tryptophan into melanin in Harding-Passey mouse melanoma 
(43) , which would explain the toxicity of this amino acid. 
In addition, pretreatment of cells with MSH increased mela¬ 
nin synthesis and as predicted, rendered the melanoma cells 
more susceptible to the toxicity of tyrosine (25) and dopa 
(44) . Treatment of cells with phenylthiourea, a potent in¬ 
hibitor of tyrosinase, provided protection from the toxicity 
of tyrosine (25). 
Studies by wick et. al. have shown that both dopa (45) 
and its analogue, 6-hydroxydopa (46), exert selective inhi¬ 
bition of growth in pigmented cell lines. Melanotic S-91 
melanoma cells, exposed to dopa (6 mM) for one hour, showed 
a 60% decrease in cell number when counted 48 hr later. In 
comparison, human melanoma cells showed a decrease of 35% 
while dopa had no effect on the amelanotic S-91 cells and 
the mouse fibroblasts (45). These findings are similar to 
those made by Pawelek (25) and substantiate the selective 
cytotoxicity of dopa, the first intermediate in the melanin 
pathway. 
Wick has also observed that the toxicity of dopa and 
. . 
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6-hydroxydopa paralled the ability of various cell lines to 
incorporate dopa (47). For example, the melanotic melanoma 
cells incorporated dopa up to 60 times that of amelanotic 
cell lines. On the other hand, tyrosine showed no selective 
uptake. The inability to detect a selective accumulation of 
tyrosine in pigmented cells was explained by the finding that 
an estimated 95°/° of the tyrosine incorporated into cells was 
used for protein synthesis. The explanation for dopa's se¬ 
lective incorporation was its lack of alternate routes of 
metabolism other than melanin synthesis. 
Cytotoxicity studies reported in the past year by 
Pawelek and Lerner have demonstrated the potent toxicity of 
5,6-dihydroxyindole, a melanin precursor two steps removed 
from the final product, melanin (44). When a comparison of 
dose-responses was made, 5»6-dihydroxyindole was more toxic, 
as reflected by inhibition of thymidine incorporation, than 
dopa. However, 5*6-dihydroxyindole exhibited a wider range 
of cytotoxicity than dopa, killing both pigmented cells and 
mouse fibroblasts (44). To date, three of the melanin path¬ 
way intermediates, tyrosine, dopa, and 5*6-dihydroxyindole, 
have been shown to inhibit cellular growth of melanomas. 
B. Hypothesis 
The work in this thesis was based upon three observa- 
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tionsi (1) When S-91 melanoma cells are pretreated with MSH, 
they display increased sensitivity to the cytotoxic effects 
of the melanin precursors tyrosine and dopa (25,44). The 
explanation for this effect was an increase in tyrosinase 
activity, leading to an increase in the rate of production 
of melanin precursors. (2) Extracts from cells not exposed 
to MSH contain a block in the melanin pathway and are unable 
to convert dopachrome to melanin even though conversion of 
dopachrome to melanin can occur spontaneously within an 
hour (28). (3) Pretreatment of the cells with MSH removed 
this block (28). 
The studies described here provide evidence for a more 
distal site of regulation in the melanin pathway than ty¬ 
rosinase. The hypothesis was that the above mentioned block¬ 
ing factor could influence the cytotoxicity of dopachrome. 
Dopachrome is a melanin precursor whose conversion to melanin 
is independent of tyrosinase, but dependent upon the absence 
of this blocking factor. Theoretically, treatment of the 
cells with MSH would remove the inhibitory factor and allow 
the intracellular concentration of toxic dopachrome deriva¬ 
tives to increase. The major finding of this study is that 
the cytotoxicity of dopachrome is increased when the melanoma 
cells are pretreated with MSH. In conclusion, this inhibi¬ 
tory factor appears to protect cells from the cytotoxic ef¬ 
fects of melanin precursors, and it is removed when the cells 
are exposed to MSH. 
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MATERIALS Am METHODS 
Cell lines 
Cloudman S-91 murine melanoma cells, clone M-3» CCL- 
53*1» were obtained from the American Type Cell Culture Re¬ 
pository (48). Isogenous pigmented cell lines were esta¬ 
blished by sub-cloning in soft agar (42,49), including the 
PS1-HGPRT-1 (hypoxanthine-guanine phosphoribosyl transferase 
deficient) cell line here referred to as wild type. This 
line was originally isolated because of its resistance to 
6-thioguanine and 8-azaguanine following ethylmethane sul¬ 
fonate treatment of the parental cell line (13)* The phe¬ 
notype of the PS1-HGPRT-1 cell line was one of low basal 
tyrosinase activity which increased 5-50 fold after 15 hr of 
exposure to MSH (12). 
In addition to the wild type, two clones of melanoma 
cells resistant to the inhibitory effects of MSH on growth 
were used in these experiments (50). One clone was melanotic 
in the presence of MSH and was designated mel-1. A second 
clone was amelanotic in the presence of MSH and was called 
amel-1. In the absence of MSH, both lines were amelanotic 
and had tyrosinase activity 4 5f« of that found in the wild 
type. In the presence of MSH, only the mel-1 line showed a 
significant rise in tyrosinase activity (50). 
. . . .. .. . 
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Cell Culture 
Cells were grown as monolayers in Corning tissue cul¬ 
ture flasks in Ham's F10 nutrient medium (51) supplemented 
with 2% fetal calf serum (Flow Labs), 10% horse serum (Flow 
Labs), 1.2 mg/ml of sodium bicarbonate, 100 U/ml of penicil¬ 
lin, and 100 /Ug/ml of streptomycin. (Neither antibiotic 
affected pigment formation (52).) Cells were incubated at 
37°C in a humidified incubator with 5% C02-95% air. Fresh 
culture medium was added three times per week. Subculturing 
involved removal of culture medium and addition of Joklik's 
medium (Difco) containing ethylenediaminetetracetic acid 
(FDTA) (5 mM) for 10 min at 25°C. This was followed by cen¬ 
trifugation of detached cells, resuspension in fresh medium, 
and inoculation into flasks. 
Preparation of dopachrome 
Dopachrome was synthesized by the addition of ice cold 
dopa (0.5 or 1.0 mg/ml 0.1 M potassium phosphate buffer pH 
6.8) to solid Ag20 [30 mg Ag20 : 1 mg dopal (17) for approx¬ 
imately one min or until the desired red-orange color was 
obtained. The mixture was shaken during this period, then 
filtered through a Gelman Acrodisc Disposable Filter 4192 
with 0.2 jam diameter pores. After 15-20 min on ice, the op¬ 
tical density at 475 nyu was measured on a spectrophotometer. 
. 
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UViaximum absorption for dopachrome = 305 mju, 4-75 mju) Using 
the formula optical density (ODJ = molecular extinction co¬ 
efficient (£) x concentration in moles per liter (C), the 
concentration of dopachrome was calculated. ^dopachrome = 
3520, pH 6.7 (39)) L-dopa was obtained from Hoffman-LaRoche. 
3 
^H-Thvmidine incorporation 
Effect of dopa and dopachrome -lx 10^ wild type mel- 
2 
anoma cells in 5 ml media were seeded into 25 cm Corning 
tissue culture flasks. 24- hr later, the medium was removed 
and replaced with fresh medium containing either 0.1 M potas- 
-4- 
sium phosphate buffer pH 6.8, dopa (2.5 x 10 M), or dopa¬ 
chrome (7 x 10”%), as well as £%] thymidine (methyl-%3 
(Hew England Nuclear), specific activity of 30 Ci/mmol in a 
concentration of 1 juCi/ml. The flasks were incubated at 
37^0. At times 30 min, 1, 2, and 4 hr, the amount of %- 
thymidine incorporated into acid-precipitable material was 
determined by the following method. 
. . 3 The medium containing the -'H-thymidme was removed. The 
«|« *|b 
cells were then harvested in 10 ml of EDTA (5 mM) in Ca 
++ 
Mg free Tyrode salt solution with 0.5 mg/ml non-radioactive 
thymidine. A 1 ml sample of the suspended cells was taken 
and counted in a Coulter counter. The remaining 9 ml were 
centrifuged (1500g, 10 min at 4°C), resuspended in 4 ml ice- 
■ 
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cold 0.9^> NaGl with 0.5 mg/ml thymidine, and precipitated 
with 4 ml ice-cold 10^ trichloroacetic acid containing 0.5 
mg/ml thymidine. After 15 min at , the acid precipitates 
were filtered onto 0.45 Mm Millipore filters and were washed 
5 times with 5 ml ice-cold 5% trichloroacetic acid contain¬ 
ing 0.5 mg/ml thymidine. Two ml of scintillation fluid were 
added to the filters and the samples were counted in a Beck¬ 
man scintillation counter 16 hr later, at which time the 
3 ... . . filters had dissolved. -'H-thymidine incorporation into acid- 
precipitable material was expressed as c.p.m./10^ cells. 
In order to construct a dose-response curve, wild type 
cells were seeded as above. 24 hr later, fresh medium was 
added containing either 0.1 M potassium phosphate buffer pH 
6.8, dopa (1 x 10""^M to 1 x 10_%i) , or dopachrome (4 x 10”Sl 
to 3 x 10”^M), in addition to ^H-thymidine (1 juCi/ml). The 
cells were harvested at 90 min and the acid-precipitable 
material was assayed. 
Effect of pretreatment with MSH - Wild type and mel-1 
melanoma cells at 1 x 10^ cells per flask were grown in 5 ml 
medium. The medium contained either no additions or MSH (2 
x 10~^M) and 3~isobutyl-l-methylxanthine (MIX) (1 x lO'^M). 
MIX is a potent inhibitor of cyclic nucleotide phosphodies¬ 
terase (53) and has been shown to increase the intracellular 
content of both melanin and cyclic AMP in B-l6 melanoma cells 
■ 
■ 
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(54). Phosphodiesterase inhibitors, including theophylline 
and MIX, have been used to potentiate the effects of MSH (44, 
50,55)* Cells were incubated for 24 or 4b hr. The medium 
was then replaced with fresh medium containing either phos¬ 
phate buffer or dopachrome (4-8 x 10~^M), as well as %- 
thymidine (1 /uCi/ml). Cells from triplicate flasks were har¬ 
vested at 90 min and acid-precipitable material assayed for 
3 ... 
^H-thymidine incorporation as above. MSH was prepared by 
Drs. A. Lerner and S. Lande. MIX was obtained from Aldrich 
Chem Co. 
Growth inhibition 
Effect of melanin precursors - Wild type, mel-1, or 
amel-1 melanoma cells were seeded at 1 x 10^ cells in 2.5 ml 
medium. After approximately 3 hr, when the cells had at¬ 
tached, 2.5 ml of medium was added, containing either no ad¬ 
ditions or MSH and MIX. The final concentrations of MSH and 
-7 -4 MIX were 2 x 10 'M and 1 x 10 M, respectively. The cells 
were incubated for 48 hr at The medium was then removed 
and replaced with fresh medium containing either 0.1 M po¬ 
tassium phosphate buffer, phosphate buffer previously mixed 
with solid Ag20 and filtered, dopa (1 x 10~^M to 1 x 10~-^M), 
—4 —6 
or dopachrome (5 x 10 M to 5 x 10 M) . Following the mix¬ 
ture of phosphate buffer and solid Ag20, no change in color 
, . I 
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was noted. After 2 hr of incubation at 37°C, the medium was 
removed and the cells were washed with 5 ml of fresh medium 
and then reincubated with 5 ml fresh medium for 0, 24, or 
48 hr. Media and detached cells were removed and 10 ml of 
EDTA (5 mM) in Ca++-Mg"H’ free Tyrodes solution was added for 
10 min at 37°C . Cells were harvested and counted in a Coul¬ 
ter counter. After 24 hr, a 10# reduction in cell number 
was observed in the cultures treated with the phosphate buf¬ 
fer that had been previously mixed with Ag20 in comparison 
to the control. This effect was non-specific, i.e. it was 
seen in both MSH- and non-MSH-treated amel-1 and mel-1 cells. 
The detached cells were also counted, inoculated with 
fresh medium into new flasks, and studied with 0.4# trypan 
blue stain. 
Effect of MSH versus MIX -lx 10^ amel-1 or mel-1 
cells were seeded in 2.5 ml medium as above. Three hr 
later, 2.5 ml medium containing either no additions, MIX, 
MSH, or MSH and MIX were added. The final concentrations of 
MSH and MIX were 1 x 10”% and 5 x 10""%, respectively. The 
cells were incubated for 48 hr. Medium was then removed 
and replaced with fresh medium containing either dopachrome 
^4—8 x 10~%) or phosphate buffer previously mixed with Ag20. 
After 2 hr of incubation, the medium was removed and the 
cells were washed with fresh medium and reincubated for 24 
. 
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hr. Cells were harvested as above and counted. 
Effect of dibutvrvl cyclic AMP -lx 10^ mel-1 cells 
were inoculated in 2.5 ml medium as described previously. 
Three hr later, 2.5 ml medium containing either no addi¬ 
tions, MSH and MIX, or dibutyryl cyclic AMP was added. 
Final concentrations of MSH, MIX, and dibutyryl cyclic AMP 
were 2 x 10~%, 5 x 10"%, and 1 x 10~%, respectively. 
After 48 hr, the medium was removed and replaced with medi- 
-4 
um containing either dopa (2.5 x 10 M), dopachrome (8 x 
10~%), phosphate buffer, or buffer previously mixed with 
Ag20. After 2 hr of incubation, the medium was removed and 
cells were washed with fresh medium and reincubated for 24 
hr. Cells were harvested as above and counted. 
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RESULTS 
Thymidine incorporation studies 
Effect of dopa and dopachrome - Wild type cells exposed 
3 . . 
to dopa or dopachrome simultaneously with ^H-thymidine exhib- 
3 
ited a reduction m the rate of incorporation of •'H-thymidine 
into acid-precipitable material (Fig. 2). Dopachrome was 
clearly more effective in reducing this incorporation (c.p.m. 
/ 10^ cells) than dopa. After 4 hr of incubation with dopa¬ 
chrome, ^H-thymidine incorporation was approximately 15% of 
the control value. By this time, many of the cells exposed 
to dopachrome had either lysed or were rounded and float¬ 
ing in the medium. On the other hand, cells exposed to dopa 
had the same morphology as the controls. 
A dose-response curve was constructed by comparing the 
effects of various concentrations of dopa and dopachrome on 
"\h-thymidine incorporation (Fig. 3) • To achieve a 50% re¬ 
duction in the incorporation of thymidine, about twenty 
times more dopa than dopachrome was required. 
Effect of pretreatment with MSH - Following 48 hr of 
incubation with MSH and MIX, the wild type melanoma cells 
had a noticeable increase in melanin formation and their 
shape was more flattened with increased dendritic processes 
(Fig. 4 a,b). Similar observations have been made previously 
- 
11.90 
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(4). Treatment with MSH and MIX for 48 hr markedly de= 
creased the incorporation of ^H-thymidine into acid-precip- 
itable material and the addition of dopachrome did result in 
a further decrease (Fig. 5)• However, incubation with MSH/ 
MIX resulted in such a degree of inhibition that the value 
could not be used as a sensitive control. Decreasing the 
time of exposure to MSH/MIX to 24 hr resulted in similar 
responses. Fortunately, a second assay, based upon cell 
counts taken 24 hr after exposure to melanin precursors, 
proved to be a more sensitive measure of cytotoxicity. 
Cell viability studies 
Effect of oretreatment with MSH - After 2 hr of incu¬ 
bation of wild type melanoma cells with dopachrome, the cul¬ 
ture medium had turned dark. If cells had been previously 
treated with MSH and MIX, dopachrome caused them to round up 
and many were floating in the medium or were attached only 
by fine dendritic processes (Fig. 4 c,d). In contrast, cells 
without any pretreatment had the same morphology as control 
cells when exposed to dopachrome. The toxic changes which 
resulted from dopachrome and MSH/MIX treatment first began 
to appear at an incubation time of 60 min. On the other 
hand, the cells exposed to dopa had no change in morphology, 
regardless of pretreatment. 
. 
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Figure 6 shows the effect of pretreatment with MSH/MIX 
on cellular growth inhibition 24 hr after exposure to dopa 
or dopachrome. Results are expressed as a percentage of the 
control cell count according to the formula (number of 
treated cells/number of control cells) x 100. On the aver¬ 
age, there were 15# less cells as the control figure for the 
MSH-treated cells as compared to the non-MSH-treated cells. 
Dopachrome alone was able to inhibit cellular growth to 
a greater extent than dopa, even though lower concentrations 
of dopachrome were employed (Fig. 6). Although no inhibition 
-4 
of growth was seen in cells exposed to dopa (1.2 x 10 M) for 
2 hr, dopachrome (8 x 10”%) resulted in a cell count of 54% 
as compared to the control. In addition, exposure to dopa¬ 
chrome after treatment with MSH/MIX resulted in a marked de¬ 
crease in cell number. A cell count of 5^°/° was observed 
with dopachrome (8 x 10”%) alone, whereas a count of 21% 
was seen with the combination of MSH, MIX, and dopachrome. 
As previously described (44), a greater degree of growth in¬ 
hibition was seen with dopa plus MSH/MIX than with dopa 
alone. 
Two dose response curves were constructed by comparing 
the effects of various concentrations of dopa and dopachrome 
on the growth of either mel-1 or amel-1 cells (Fig. 7) • 
Similar results were seen with the amel-1 cells when they 
were counted 48 hr following exposure to dopa or dopachrome. 
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Dopachrome by itself was observed to be more toxic than 
dopa in both mel-1 and amel-1 cells (Fig. 7). Even with MSH/ 
MIX pretreatment, dopa had no effect on the amel-1 cells. 
In both mel-1 and wild type cell cultures, a greater degree 
of growth inhibition was seen with dopa plus MSH/MIX than 
with dopa alone. Pretreatment with MSH/MIX also enhanced 
the growth inhibition of dopachrome in both mel-1 and amel-1 
cells. In mel-1 cells, dopachrome resulted in a 50% reduc- 
-4 
tion in cell number at a concentration of 3*5 x 10 M; if 
the cells were first treated with MSH/MIX, a concentration 
of 7 x 10~^vl had the same effect (Table 1). In mel-1 cells, 
the enhancement of dopachrome's cytotoxicity by MSH/MIX was 
more marked than in amel-1 cells and similar to that seen in 
wild type cells (Fig. 8). Following MSH/MIX treatment and 
exposure to dopachrome for 2 hr, a 50% reduction in cell 
-4 
count was observed at a concentration of 2.5 x 10 M in 
amel-1 cells and a concentration of 7 x 10* in mel-1 cells 
(Table 1). 
In one study, cell counts were done immediately follow¬ 
ing the 2 hr exposure to either dopa or dopachrome rather 
than 24 hr later. At this earlier time point, the number 
of cells attached in the dopa- or dopachrome-treated cul¬ 
tures was the same as in untreated control cultures. 
Cell counts of the freely floating cells that were re¬ 
moved with the medium did not account for the differences in 
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the values for attached cells. This indicated that dopa- 
chrorae caused cellular lysis rather than simply a detachment 
of the cells from the flask. The cells that did detach be¬ 
cause of dopachrome treatment were not viable in that 90% of 
these cells were unable to exclude the dye trypan blue and 
could not reattach in fresh culture medium. 
Individual effects of MSH. MIX, and dibutyryl cyclic 
AMP - Exposure to MIX (5 x 10”%) for 48 hr had no effect on 
dopachrome toxicity (Pig. 9)• With MIX pretreatment, the 
cell count was 76% of the control figure and with dopachrome 
alone, it was 71%. Incubation with MSH (1 x 10”%) led to a 
growth figure of 61% 24 hr after dopachrome exposure, while 
the combination of MSH/MIX resulted in a cell count of 48%. 
Although MIX by itself had no effect on growth inhibition, 
it did potentiate the effects of MSH. 
When the cells were exposed to dibutyryl cyclic AMP 
(1 mM) for 48 hr, then dopachrome (8 x 10”%) for 2 hr, 
they exhibited growth inhibition comparable to that seen 
with MSH/MIX pretreatment (Pig. 10). Cell counts were 39% 
with dibutyryl cyclic AMP pretreatment and 30% with MSH/MIX 
pretreatment. In the case of treatment with dopa, dibutyryl 
cyclic AMP resulted in more marked cellular inhibition than 
MSH/MIX. 
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DISCUSSION 
In the present studies, dopachrome was shown to be a 
melanin precursor with potent toxic effects on S-91 melanoma 
cells. Dopachrome's cytotoxic properties were reflected in 
both decreased thymidine incorporation (Fig. 2,3) and in¬ 
creased growth inhibition (Fig. 7). In both MSH- and non- 
MSH-treated cells, dopachrome was more effective than either 
dopa or Ag20-treated buffer. For example, about twenty 
times more dopa than dopachrome was required to achieve a 
50% reduction in the incorporation of thymidine (Fig. 3)• 
Further investigations supported the hypothesis that 
pretreatment of melanoma cells with MSH would increase the 
cytotoxicity of dopachrome. When the exposure of wild type 
cells to dopachrome was preceded by incubation with MSH/MIX, 
a reduction in cell count from 54% (dopachrome alone) to 21% 
was seen (Fig. 6). A similar degree of growth inhibition 
was seen in mel-1 cells and to a lesser extent in arnel-1 
cells (Fig. 8). Following incubation with MSH/MIX for 48 hr 
and exposure to dopachrome for 2 hr, a 50% reduction in cell 
. -4 
count was observed at a concentration of 2.5 x 10 M m 
amel-1 cells and a concentration of 7 x 10~^M in mel-1 cells 
(Table 1). 
The above results provide evidence for a more distal 
site of regulation in the pathway of melanin synthesis than 
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that of tyrosinase. First of all, dopachrome's further con¬ 
version was independent of tyrosinase and yet its cytotoxic¬ 
ity was increased by pretreatment with MSH. Secondly, this 
increased toxicity was seen in the amel-1 cells, which have 
negligible tyrosinase activity (50). Parallel studies in 
this laboratory showed that extracts of non-MSH treated cells 
contain an inhibitory factor which blocks the spontaneous 
conversion of dopachrome to melanin, and pretreatment of 
cells with MSH removed this factor (28). The results pre¬ 
sented here suggest that this inhibitory factor which blocks 
melanogenesis also protects the cells from the toxicity of 
melanin precursors. 
Based upon the studies described here, cyclic AMP is a 
likely agent in the removal of the inhibitory factor by MSH. 
Dibutyryl cyclic AMP, an analogue of cyclic AMP, was able 
to mimic the effects of MSH/MIX on growth inhibition of mel¬ 
anoma cells. After a 2 hr exposure to dopachrome, a cell 
count of 30% was seen 24 hr later if cells were pretreated 
with MSH/MIX and a count of 39% if dibutyryl cyclic AMP (1 
mM) was the pretreatment (Fig. 10). This particular concen¬ 
tration of dibutyryl cyclic AMP was chosen because it results 
in the same cellular changes as MSH - an increase in pigmen¬ 
tation and dendritic processes and a marked slowing of cell¬ 
ular proliferation (50). 
Once evidence for an inhibitory factor was provided, the 
* 
, 
* { 
' 
■ 
* 
-24- 
next step was to localize the point at which the inhibition 
was exerted. One clue was the observation that if extracts 
of non-MSH treated cells (presumably containing the factor) 
were added to dopachrome, the solution turned from orange 
to colorless and remained colorless for 24 hr (Fig. 1). 
Therefore, the point of regulation was beyond the conversion 
of dopachrome to 5.6-dihydroxyindole, the step catalyzed by 
the factor "DCF" (27). As a further step, the reaction pro¬ 
ducts resulting from the mixture of dopachrome and extract 
from non-MSH treated cells were examined by high pressure 
liquid chromatography. The major component was 5.6-dihy- 
droxyindole (28), making the conversion of 5*6-dihydroxyin¬ 
dole to indole-5.b-quinone the most likely point of inhibi¬ 
tion. 
As a result of the MSH-controlled inhibitory factor, 
5.6-dihydroxyindole would accumulate in non-MSH treated 
cells, while indole-5.6-quinone would be formed in MSH 
treated cells. Therefore, the increased cell killing seen 
in MSH treated cells is most likely secondary to the in¬ 
creased intracellular concentration of indole-5.6-quinone. 
Quinones are known sulfhydryl group scavengers, thus inhibit 
ing key enzymes in DNA synthesis (38) and cellular respira¬ 
tion (37)* It seems likely therefore that the quinone inter 
mediates are the toxic precursors in the melanin pathway. 
Beyond the interest generated by the possibility of a 
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second MSH-controlled regulation point, the implications 
for chemotherapy of human melanoma must be considered. In 
the studies described here, incubation of melanoma cells 
with MSH/MIX for 4b hr and subsequent exposure to dopachrome 
(b x 10”%) for only 2 hr resulted in a cell count which was 
207® of the control value, i.e. a growth inhibition of 80%. 
In a similar in vitro investigation by Wick et. al.. dopa 
(6 mM) resulted in a growth inhibition of 60% in melanotic 
S-91 cells (45) and 6-hydroxydopa (10 ug/ml) an inhibition 
of 75% (46). In the present studies, however, dopa alone 
had little effect on cellular growth (Fig. 6). This dis¬ 
crepancy can be explained by the fact that Wick £t. al. 
used about 20-40 times more dopa in their experiments. As 
compared to dopa (6 mM), dopachrome produced more inhibition 
at l/100th the concentration. 
There has been, however, an obvious lack of correlation 
between in vitro toxicity and in vivo toxicity. For in¬ 
stance, when 6-hydroxydopa was tested against B-16 and S-91 
melanoma in vivo. no significant prolongation in the survival 
of treated animals was seen (46). In studies with dopa, this 
melanin precursor did result in a slight (20%) prolongation 
of the survival of mice bearing B-l6 melanoma (57) and en¬ 
hancement of L-dopa incorporation into melanoma in vivo has 
been accomplished by inhibiting dopa decarboxylase (58)• 
However, a temporal relationship has been reported between 
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the initiation of L-dopa therapy for Parkinsonism and growth 
of melanoma (59*60,61), These observations make the testing 
in vivo of the combination of MSH and dopachrome imperative 
prior to making further claims regarding its application to 
chemotherapy of melanoma. 
In conclusion, a second MSH-controlled point of regula¬ 
tion in the melanin pathway has been suggested by cytotoxic¬ 
ity studies. Further investigations are being conducted to 
isolate and identify this particular inhibitory factor. In 
addition, the in vivo cytotoxicity of dopachrome when coupled 
with MSH pretreatment is being tested. Perhaps these find¬ 
ings will bear favorably upon the future chemotherapy of 
human melanoma. The toxicity of melanin precursors would 
be utilized in this form of chemotherapy "in which the color 
of melanin indeed becomes a blush of metabolic embarrassment" 
(29) . 
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Figure 1: The classical pathway of melanin biosynthesis, 
modified slightly from the scheme of Mason and 
Kaper (62) . 
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Figure 1 
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f\y£ure__2s Effects of dopa and dopachrome on the rate of 
thymidine incorporation into acid-precipitable 
material in wild type melanoma cells. At the 
3 
times indicated the amount of -thymidine in¬ 
corporation into acid-precipitable material 
was determined in triplicate culture flasks. 
Variation was less than + 15%• The experiment 
was repeated once, with similar results. O* 
-4 
phosphate buffer; #, dopa (2.5 x 10 M) ; A. 
dopachrome (7 x 10~^M). 
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Figure 2 
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figure 3: Effects of various concentrations of dopa and 
dopachrome on thymidine incorporation into acid- 
precipitable material in wild type melanoma 
cells. Dopa (O) and dopachrome (#) were 
added at the concentrations indicated. After 4 
3 ... . . 
hr the amount of ■'H-thymidine incorporation into 
acid-precipitable material was determined in 
triplicate flasks. Variation was less than ± 
15#>. The experiment was repeated once, with 
similar results. 
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Figure 3 
Thymidine incorporation (c.p.m./10^ cells) 
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Figure 4: Phase contrast photographs of wild type melanoma 
cells grown for 48 hr in normal medium (left) or 
medium containing MSH/MIX (right). Upper: cells 
were exposed to phosphate buffer for 2 hr; lower: 
cells were exposed to dopachrome (8 x 10 ^M) for 
2 hr. 
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Figure 4 
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Figure 5: Effect of pretreatment with MSH/MIX on thymi¬ 
dine incorporation into acid-precipitable ma¬ 
terial in wild type melanoma cells. Following 
48 hr of growth in medium containing either no 
additions l !"""">) or MSH/MIX (ESSJj * cells were 
exposed to phosphate buffer or dopachrome (4 
or 8 x 10 it) simultaneously with -'H-thymidine. 
3 ... After 2 hr the amount of -'H-thymidme incorpor¬ 
ation into acid-precipitable material was de¬ 
termined in triplicate flasks. Variation was 
less than + 15#. The experiment was repeated 
three times, with similar results. 
„ wr- ir- »• * . i. »■. •, x 
, ■. 
. 
» AC. - 
. 
T
hy
m
id
in
e 
in
c
o
rp
o
ra
ti
o
n
 
(c
.p
.m
./l
O
'5 
c
e
ll
s)
 
“36- 
Figure 5 
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Figure 6: Effect of pretreatment with MSH/MIX on the via¬ 
bility of wild type melanoma cells following 
exposure to dopa or dopachrome. Following 48 
hr of growth in medium containing either no ad¬ 
ditions if”)) or MSH/MIX (GSI) * cells were ex¬ 
posed to phosphate buffer, dopa (1.2 or 2.5 x 
10 "\), or dopachrome (4 or 8 x 10“%) for 2 hr. 
After 24 hr cell counts of triplicate flasks 
were made. Variation was less than ± 15%• The 
experiment was repeated once, with similar re¬ 
sults . 
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Figure 7: Effect of pretreatment with MSH/MIX on the 
toxicity of dopa and dopachrome against mel-1 
and amel-1 melanoma cells. Following 4d hr of 
growth in medium containing either no additions 
or MSH/MIX, cells were exposed to dopa or dopa¬ 
chrome at the concentrations indicated for 2 hr. 
Control cultures received either duffer that 
had been mixed with Ag20 and filtered or buffer 
alone. After 24 hr cell counts of quadruplicate 
flasks were made. Variation was less than + 
lOJfe. Limited versions of these experiments 
were repeated twice, with similar results. 
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Figure 8: Effect of preincubation with MSH/MIX on tne 
toxicity of dopachrome in three melanoma cell 
lines. Following 4b hr of growth in medium con¬ 
taining either no additions (C3) or MSH/MIX 
(IwVf) . wild type, mel-1 and amel-1 melanoma 
cells were exposed to dopachrome (4 or b x 
10~^M) for 2 hr. After 24 hr cell counts of 
triplicate flasks were made. Variation was less 
than + 10%. The experiment was repeated once, 
with similar results. 
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Figure 8 
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Figure 9: Effect of preincubation with MSH versus MIX 
on the toxicity of dopachrorae. Following 48 
hr of growth in medium containing MSH, MIX, 
MSH/MIX, or no additions, cells were exposed 
to dopachrome (8 x 10~^M) for 2 hr. After 
24 hr cell counts of triplicate flasks were 
made. Variation was less than + 10%. The 
experiment was repeated once, with similar 
results. 
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Figure 9 
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Figure 10: Effect of preincubation with MSH/MIX versus 
dibutyryl cyclic AMP on the cytotoxicity of 
dopa and dopachrome in melanoma cells. Fol¬ 
lowing 48 hr of growth in medium containing 
MSH/MIX (023) , dibutyryl cyclic AMP (£23) , 
or no additions (fsH.), cells were exposed to 
dopa (2.5 x lO^M) or dopachrome (8 x 10"’%) 
for 2 hr. Control cultures received either 
buffer that had been mixed with Ag20 and fil¬ 
tered or buffer alone. After 24 hr cell 
counts of triplicate flasks were made. Var¬ 
iation was less than + 10%. 
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Figure 10 
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Table 1: Concentration of dopa and dopachrorae required for 
50jo reduction in cell number 
Treatment Concentration for 50% Reduction 
MSH-responsive Ron-responsive 
Cells Amelanotic Variants 
Rone 
Dopa 
Dopa + MSH 
Dopachrome 
Dopachrome + MSH 
1.5 x 10“% 
3.5 x 10 Al 
7 x 10“% 
4.5 x 10 A 
2.5 x 10Ai 
*The experimental design is described in the legend to Fig. 
7. 
. 
— * • •*“ — 
• 
• K <• t 
. -i a 
. 
r ~ 
- 
■ 
. 
-48- 
BIBLIOGRAPHY 
1. Cloudman, A.M.: The effect of an extra-chromosomal influ¬ 
ence upon transplanted spontaneous tumors in mice. 
Science 93:380-381, 1941. 
2. Yasumura, Y., Tashjian, A.H., and Sato, G.H.; Establish¬ 
ment of four functional, clonal strains of animal cells 
in culture. Science 154: 1186-1189, 1966. 
3. Wong, G., and Pawelek, J.: Control of cultured melanoma 
cells by melanocyte stimulating hormone. J. Cell Biol. 
55s 288a, 1972. 
4. Wong, G., and Pawelek, J.j Control of phenotypic ex¬ 
pression of cultured melanoma cells by melanocyte stimu¬ 
lating hormones. Nat. New Biol. 24l* 213-215, 1973* 
5. Geschwind, 1.1., and Huseby, R.A.: Hormonal modification 
of coat color in the laboratory mouse. J. Invest. 
Dermatol. 54: 87a, 1970. 
6. Lee, T.H., Lee, M.S., and Lu, M.: Effects of oC-MSH on 
melanogenesis and tyrosinase of B-l6 melanoma. Endocrin¬ 
ology 91: 1180-1188, 1972. 
7. Bitensky, M.W., and Demopoulos, H.B.: Activation of mel¬ 
anoma adenyl cyclase by MSH. J. Invest. Dermatol. 54: 
83a, 1970. 
8. Kreiner, P.W., Gold, C.J., Keirns, J.J., Brock, W.A., and 
Bitensky, M.W.: MSH-sensitive adenyl cyclase in the Cloud¬ 
man melanoma. Yale J. Biol. Med. 46: 583-591* 1973* 
* 
, V , . L . 1 , . 
. , ~ , 1 )• 
. 
. 
. 
. . • • 
. , . , 
. 
■ 
. 
, 
• c 
, • • 0 < JI.'J - 1 -1 
, , . . . . . 
-49- 
6 2' 9. Johnson, G.S., and Pastan, I.: N ,0 -dibutyryl adenosine 
3’,5'-monophosphate induces pigment production in mela¬ 
noma cells. Nat. New Biol. 237s 267-268, 1972. 
10. Pawelek, J., Wong, G., Sansone, M., and Morowitz, J.s 
Molecular controls in mammalian pigmentation. Yale J. 
Biol. Med. 46: 430-443, 1973* 
11. Wong, G., Pawelek, J., Sansone, M., and Morowitz, J.s 
Response of mouse melanoma cells to melanocyte stimulat¬ 
ing hormone. Nature 248s 351-35^. 1974. 
12. Korner, A., Pawelek, J.s Activation of melanoma tyrosin¬ 
ase by a cyclic AMP-dependent protein kinase in a cell- 
free system. Nature 267: 444-447, 1977. 
13. Pawelek, J., Halaban, R., and Christie, G.s Melanoma 
cells which require cyclic AMP for growth. Nature 256: 
539-5^0, 1975. 
14. Kreider, J.W., Rosenthal, M., and Lengle, N.s Cyclic 
adenosine 3'»5'-monophosphate in the control of melanoma 
cell replication and differentiation. J. Natl. Cancer 
Inst. 50: 555-556. 1973- 
15. Pawelek, J.: Evidence suggesting that a cyclic AMP- 
dependent protein kinase is a positive regulator of pro¬ 
liferation in Cloudman S-91 melanoma cells. J. Cell 
Physiol. 98: 619-626, 1979. 
16. Raper, H.S.: Some problems of tyrosine metabolism. J. 
Chem. Soc. 141: 125-130, 1936. 
* * : 
« . . , ; 
♦ 
, 
-U a 
. i ■. 
, ic. 
• . 
. . 
. 
■ 
. 
. 01. i 
. 
: - ' 
-50- 
17• Mason, H.S.: The chemistry of melanin III, Mechanism of 
the oxidation of dihydroxyphenylalanine by tyrosinase. 
J. Biol. Ghem. 172s b3-99, 19^8. 
lb. Lerner, A.B., Fitzpatrick, T.B., Galkins, E., and Summer- 
son, W.H.; Mammalian tyrosinase: preparation and proper¬ 
ties. J. Biol. Ghem. 17b: 165-195. 1949* 
19. Holstein, T.J., Stowell, C.P., Quevedo, W.C., Zarcaro, 
R.M., and Bienieki, T.C.; Peroxidase, "protyrosinase," 
and multiple forms of tyrosinase in mice. Yale J. Biol. 
Med. 46: 560-571. 1973* 
20. Hearing, V.J., Ekel, T.M.: Involvement of tyrosinase in 
melanin formation in murine melanoma. J. Invest. 
Dermatol. 64: b0-b5, 1975* 
21. white, R., and Hu, F.i Characteristics of tyrosinase in 
B-16 melanoma. J. Invest. Dermatol. 68: 272-276, 1977. 
22. Hogeboom, G.H., and Adams, M.H.: Mammalian tyrosinase 
and dopa oxidase. J. Biol. Chem. 145: 273-279, 1942. 
23. Patel, R.P., Okun, M.R, Yee, W.A., Wilgram, G.F., and 
Edelstein, L.M.: Inability of murine melanoma "tyrosin¬ 
ase" (dopa oxidase) to oxidize tyrosinase in the pre¬ 
sence or absence of dopa or dihydroxyfumarate cofactor. 
J. Invest. Dermatol. 61: 55-59. 1973* 
24. Okun, M.R., Donnellan, B., Patel, R.P., and Edelstein, 
L.M.1 Subcellular demonstration of peroxidatic oxidation 
of tyrosine to melanin using dihydroxyfumarate as co¬ 
factor in mouse melanoma cells. J. Invest. Dermatol. 61: 
60-66, 1973. 
... . ' C .1 
- 
• i ~ . • . » • ■> . 
< . ..... 
i . A . ; 
■ 
» 
. . , .... 
» • - . 
. - . ... 
i » t - .f» . * ..»*•* i i « . 
- 
. . •. • . . i 
. 
-51- 
25* Pawelek, J.M.s Factors regulating growth and pigmenta¬ 
tion of melanoma cells. J. Invest. Dermatol. 66: 201- 
209, 1976. 
26. Logan, A., and Weatherhead, B.: Pelage color cycles and 
hair follicle tyrosinase activity in the Siberian ham¬ 
ster. J. Invest. Dermatol. 71: 295-298, 1978. 
27. Korner, A,M., and Pawelek, J.: Dopachrome conversion: a 
possible control point in melanin synthesis. J. Invest. 
Dermatol. (in press) 
28. Pawelek, J., Korner, A., Bergstrom, A., and Bologna, J.: 
F'actors regulating melanogenesis and precursor cyto¬ 
toxicity at points distal to tyrosinase activity, (sub¬ 
mitted for publication) 
29. hochstein, P., and Cohen, C.: The cytotoxicity of mela¬ 
nin precursors. Ann. NY Acad. Sci. 100: 876-884, 1963* 
30. Chavin, W.: Effects of hydroquinone and of hypophysec- 
tomy upon the pigment cells of black goldfish. J. 
Pharmacol, Exp. Ther. 142: 275-283, 1963* 
31. Snell, R.S.: Monobenzylether of hydroquinone. Arch 
Derm. 90; 63-70, 1964. 
32. Brun, R.: Effect of the ethyl ether of hydroquinone on 
pigmentation and on the cells of Langerhans. Dermato- 
logica 134: 125-128, 1967. 
33* Frenk, E., and Ott, F.t Evaluation of the toxicity of 
the monoethyl ether of hydroquinone for mammalian melano¬ 
cytes and melanoma cells. J. Invest. Dermatol. 56: 287- 
293, 1971. 
0 
. 
£ • ‘ * * • ■» . 
I' , w , . * J . 
? * 
• • » 
•• >dl . . j . | :. . jiS 
• ~ ' < . 
....... 
• ■ » ! . V: 
» . . '1 
. .. . . 
• t 
-52- 
3^« Riley, P.A.s Hydroxyanisole depigmentation: in-vivo 
studies. J. Path. 97s 185-191, 1969. 
35. Riley, P.A.: Mechanism of pigment-cell toxicity pro¬ 
duced by hydroxyanisole. J. Path. 101: 163-169, 1970. 
36. Goldberg, B., and Stern, A.: The role of the superoxide 
anion as a toxic species in the erythrocyte. Arch, 
Biochem. Biophys. 178: 216-225, 1977. 
37. Weaver, R.K., Rajagopalan, K.V., and Handler, P.s Mech¬ 
anism of action of a respiratory inhibitor from the 
gill tissue of the sporulating common mushroom, Agaricus 
bisoorus. Arch. Biochem. Biophys. 149: 541-546, 1972. 
38. Knock, F.E., Galt, R.M., Oester, Y.T., and Sylvester, 
R.s Inhibition of DNA polymerases and neoplastic cells 
by selected SH inhibitors. Oncology 26s 515-528, 1972. 
39* Graham, D.G., Tiffany, S.M., Bell, W.R., and Gutknecht, 
W.F.: Autoxidation versus covalent binding of quinones 
as the mechanism of toxicity of dopamine, 6-hydroxy- 
dopamine, and related compounds toward C1300 neuroblast¬ 
oma cells in vitro. Mol. Pharmacol. 14: 644-653, 1978. 
40. Graham, D.G., and Tiffany, S.M., Vogel, F.S.: The tox¬ 
icity of melanin precursors. J. Invest. Dermatol. 70: 
113-116, 1978. 
41. Lerner, A.B.: On the etiology of vitiligo and gray hair. 
Am. J. Med. 51* 141-147, 1971. 
42. Pawelek, J., Sansone, M., Morowitz, J., Moellmann, G., 
* 
. 
... ' 
* « - • • c 
• * • ♦ * n. . , , >1. 
* 1 • . 
» • , . 
* . H 
’ ’ - - f:„ 
... 
» . 
• ■ , 
.' • {, .k >. 
■ . . , . . 
-53- 
and Godawska, E.: Genetic control of melanization: iso¬ 
lation and analysis of amelanotic variants from cultured 
melanotic melanoma cells. Proc. Natl. Acad. Sci. 71* 
1073-1077, 197^. 
43. Costa, C., Allegri, G., and DeAntoni, A.; Studies on 
melanogenesis of tryptophan in Harding-Passey mouse mel¬ 
anoma. Acta Vitamin. Enzymol. (Milano) 29* 223-226, 
1975. 
44. Pawelek, J., and Lerner, A.B.: 5»C-Dihydroxyindole is a 
melanin precursor showing potent cytotoxicity. Nature 
276s 627-626, 197b. 
45. Wick, M.M., Byers, L., and Frei, E., Ill: L-Dopa: selec¬ 
tive toxicity for melanoma cells in vitro. Science 197* 
468-469, 1977. 
46. Wick, M.M., Byers, L., and Ratliff, J.: Selective tox¬ 
icity of 6-hydroxydopa for melanoma cells. J. Invest. 
Dermatol. 72: 67-69, 1979. 
47. Wick, M.M., and Frei, E., Ill: Selective incorporation 
of L-3»4-dihydroxyphenylalanine by S-91 Cloudman mela¬ 
noma in vitro. Cancer Res. 37* 2123-2125, 1977. 
48. The American Type Culture Collection (1972) Registry of 
animal cell lines (12301 Parklawn Dr., Rockville, Md.). 
49. Chu, M.Y., and Fischer, G.A.: The incorporation of %- 
cytosine arabinoside and its effect on murine leukemic 
cells (L5178Y). Biochem. Pharmacol. 17* 753-767, 1968. 
. 
• » ^ - •> » * * — • • • 1 
■ 
. 
. 
f 
,. 
. 
* 
* . . * 
. 
. 
.... 
. , . • . . 




YALE MEDICAL LIBRARY 
Manuscript Theses 
Unpublished theses submitted for the Master's and Doctor's degrees and 
deposited in the Yale Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 

